SCHEMBL28626757

SCHEMBL28626757

COc1c(-c2oc3ccccc3c(=O)c2Cl)ccc(C)c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.52
CYP3A4 P08684 6/20 0.52
HSD17B10 Q99714 4/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
ALDH1A1 P00352 3/20 0.52
HPGD P15428 3/20 0.52
ABCG2 Q9UNQ0 3/20 0.50
TSHR P16473 4/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
ADORA3 P0DMS8 2/20 0.49
HTT P42858 2/20 0.47
ALOX15 P16050 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAOA P21397 3/20 0.46
TP53 P04637 4/20 0.46
LMNA P02545 3/20 0.46
MAPT P10636 2/20 0.46
ALOX12 P18054 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28611606 0.88 KDM4E (0.58) KDM4ECYP3A4HSD17B10MEN1KMT2A
SCHEMBL28611642 0.83 KDM4E (0.54) KDM4ECYP3A4HSD17B10MEN1KMT2A
SCHEMBL10516279 0.76 ADORA3 (0.57) KDM4ECYP3A4HSD17B10MEN1KMT2A
SCHEMBL13648979 0.75 TP53 (0.62) KDM4ECYP3A4HSD17B10MEN1KMT2A
SCHEMBL28623634 0.75 KDM4E (0.63) KDM4ECYP3A4HSD17B10MEN1KMT2A
SCHEMBL28619628 0.75 KDM4E (0.57) KDM4ECYP3A4HSD17B10MEN1KMT2A
SCHEMBL28920726 0.74 KDM4E (0.56) KDM4ECYP3A4HSD17B10MEN1KMT2A
SCHEMBL28624211 0.73 ABCG2 (0.58) KDM4ECYP3A4HSD17B10MEN1KMT2A
SCHEMBL10516095 0.73 ADORA3 (0.54) KDM4ECYP3A4HSD17B10MEN1KMT2A
SCHEMBL4649956 0.73 KDM4E (0.80) KDM4ECYP3A4HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113301959-A Substituted chromen-4-ones for the treatment and prevention of hepatitis B virus infection 豪夫迈·罗氏有限公司 2021-08-24 CN disclosed